RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
10.65
+0.05 (0.47%)
Aug 14, 2025, 12:05 PM - Market open
RAPT Therapeutics Market Cap
RAPT Therapeutics has a market cap or net worth of $176.13 million as of August 14, 2025. Its market cap has increased by 51.08% in one year.
Market Cap
176.13M
Enterprise Value
9.52M
1-Year Change
51.08%
Ranking
Category
Stock Price
$10.65
Market Cap Chart
Since October 31, 2019, RAPT Therapeutics's market cap has decreased from $276.64M to $176.13M, a decrease of -36.33%. That is a compound annual growth rate of -7.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 180.26M | -15.46% |
| Dec 31, 2024 | 213.23M | -75.05% |
| Dec 29, 2023 | 854.75M | 27.19% |
| Dec 30, 2022 | 672.02M | -38.08% |
| Dec 31, 2021 | 1.09B | 123.77% |
| Dec 31, 2020 | 484.97M | -19.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.51B |
| Johnson & Johnson | 415.22B |
| AbbVie | 350.01B |
| UnitedHealth Group | 236.83B |
| AstraZeneca | 229.47B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 226.36B |
| Novo Nordisk | 222.88B |